Delayed detection
Potentially malignant disorders can be subtle, especially when symptoms are not severe enough to trigger specialist referral.
Patent granted
AI point-of-care
NHM pilot tested
Non-invasive screening
AI Oral Cancer Screening
Camera & Optics
HD 5MP Imaging Through a Mini Head.
Dr.Oroscope pairs a 5MP HD sensor with a narrow intraoral head designed to access the retromolar region, posterior buccal mucosa, and restricted-opening cases like OSMF and squamous cell carcinoma. Blue illumination in the 400–460nm range — alongside green and amber comparison — reveals tissue changes, lesion margins, and areas that are difficult to access with standard intraoral cameras. Adjustable intensity manages reflection from saliva and adjacent enamel.
5MP HD sensor
Mini intraoral head
400-460nm blue light
Controls & Workflow
Three Buttons. One Tablet Pipeline.
Three on-wand buttons handle every clinical input — toggle through white, blue, purple, and green-amber illumination, capture stills, and power the device single-handed. Type-C streams images directly to the connected Android tablet, where point-of-care software supports diagnostic review, registry storage, and telemedicine escalation when a case needs specialist eyes.
3 on-wand buttons
Type-C streaming
Tablet pipeline
IMAGING MODES
Three Lights. One Diagnostic Workflow.
Dr. Oroscope captures the same lesion under three distinct illumination modes — giving the AI engine the spectral inputs needed to separate inflammation from dysplasia.
PRECISION VISUALIZATION
For clear surface-level screening.
FLUORESCENCE IMAGING
Highlights mucosal abnormalities under autofluorescence.
SPECTRAL CONTRAST
Highlights hemoglobin-related contrast.
Clinical Problem
Early oral cancer screening needs to move closer to the point of care.
Population-level oral screening is difficult when access to specialists is limited, visual interpretation varies by examiner, and high-risk lesions are often noticed late.
Examiner dependency
Traditional visual checks depend heavily on training, lighting, experience, and the ability to evaluate hidden oral areas.
Public-health scale
Screening camps, colleges, hospitals, and government programs need tools that are portable, repeatable, and easy to train.
AI screening pathway
Capture, analyze, report, and refer from one chairside workflow.
A portable intraoral screening system built for clinics, institutions, camps, and public-health programs.
1Intraoral capture
2AI-assisted analysis
3Point-of-care report
Visible-Light Imaging
See Oral Lesions Beyond Normal Light.
Dr. Oroscope uses blue light in the 400-460nm range with green and amber light comparison to help visualize tissue changes, lesion margins, and hidden areas of the oral cavity. Adjustable intensity and a compact intraoral head make screening easier in posterior regions and limited mouth opening cases.
AI + Telemedicine
From Image Capture to Report and Referral.
Captured images can be processed by software for point-of-care diagnostic support, stored on connected Android/tablet/computer workflows, and escalated through telemedicine support when a case needs specialist review.
Regulatory & Trust Stack
Patent-granted product with documentation behind the clinical story.
A clear documentation trail supports institution-level conversations, from product IP and Startup India recognition to CDSCO/DCGI correspondence and ethical approvals.
Patent granted
Patent Office, Government of India. Portable intraoral cancer screening device, Design No. 394910-001.
CDSCO/DCGI documentation
NOC correspondence from the Medical Device Division supports the regulatory documentation story.
Startup India recognized
RAAMAH BIO CARE Pvt. Ltd. recognized in Healthcare & Lifesciences / Medical Devices Biomedical.
Ethical clearances
Documentation includes institutional ethics and study approvals for validation work.
Beyond Screening
A broader research direction toward personalized oral medicine.
Supporting research connects Dr. Oroscope with SNP genotyping, pharmacogenomics, and personalized oral medicine for future clinical decision support.
SNP genotyping
Research material connects oral lesion evaluation with genetic variation and disease-risk understanding.
Personalized medicine
Pharmacogenomics content supports a future-facing story around therapy selection and reduced trial-and-error care.
Clinical decision support
AI screening, patient history, images, and specialist support create a stronger referral and follow-up pathway.
Evidence & Deployment
Clinical Proof for Institution-Scale Decisions.
A concise evidence layer for buyers and program teams: publication data, MNJ Institute of Oncology and SVSIDS Mahabubnagar validation, private clinic and college use, NHM pilot deployment, outreach teams, NGOs, and measurable lesion discovery.
0
0
Published study comparing Dr. Oroscope with VELscope for oral cancer screening support.
0+ sites
0+ sites
Multi-center evaluation across key Andhra Pradesh sites, with deployment support from clinical institutions, outreach teams, and NGOs.
0+
0+
People screened across Andhra Pradesh and Telangana through clinical and outreach deployments.
~0
~0
Oral lesions identified during screening, supporting earlier documentation, review, and referral.
Where It Fits
Built for clinics, colleges, hospitals, camps, and government programs.
The product is designed to work across private care and public-health deployment, with workflows that support capture, reporting, review, and referral.
01Chairside
Dental clinics
Chairside screening, patient education, documentation, and referral support.
02Outreach
Screening camps
Portable workflow for high-risk communities and outreach programs.
03Academic
Dental colleges
Teaching, documentation, research, and multi-center validation use cases.
04Clinical
Hospitals
Oral medicine, oncology referral, and follow-up documentation pathways.
05Public health
Government programs
Population screening support with reporting and telemedicine potential.
06Remote review
Telemedicine networks
Store, transfer, review, and escalate doubtful cases to specialists.
The Screening Workflow. Simplified.
01
Capture
Capture intraoral images with the compact handheld device, even in hidden or posterior areas.
02
Illuminate
Use blue light and green/amber comparison modes to visualize tissue changes beyond normal light.
03
Analyze
Let the software process images, filters, history, and lesion characteristics for AI-assisted support.
04
Report
Generate point-of-care reports and escalate doubtful cases through telemedicine support.
Discuss a clinical demo, institutional evaluation, or screening-program rollout with a patent-granted AI oral screening platform.